Published on 26 Apr 2024 on GuruFocus.com via Yahoo Finance
Reported net sales: $1.68 billion, a decrease of 5.6% year-over-year, falling short of estimates of $1.68 billion.Net income: $60 million, down from $121.5 million in the prior year, significantly below estimates of $135.14 million.Diluted GAAP EPS: $0.09, with adjusted EPS at $0.22, surpassing the estimated EPS of $0.20.Operating cash flow: Reported at $142 million with free cash flow of $107 million.Adjusted EBITDA: $283 million, with an Adjusted EBITDA margin of 16.8%.Organic sales decline: Reported a 6.3% decrease on an organic basis.Segment performance: Laboratory Solutions net sales decreased by 3.8% to $1.157 billion; Bioscience Production net sales fell by 9.5% to $523 million.
Warning! GuruFocus has detected 7 Warning Sign with AVTR.